Interstitial collagen give fetal membranes tensile strength and membrane rupture has been attributed to collagen degradation. A polymorphism at -1607 in the matrix metalloproteinase-1 (MMP-1) promoter (an insertion of a guanine (G)) creates a core Ets binding site and increases promoter activity. We investigated if this polymorphism is functionally significant for MMP-1 expression in amnion cells, and if it is associated with preterm premature rupture of the membranes (PPROM). The 2G promoter had > 2-fold greater activity than the 1G allele in amnion mesenchymal cells and WISH amnion cells.
Methods

Subjects
Subjects in this study were off-spring of African American women receiving obstetrical care at the Hospital of the University of Pennsylvania, Philadelphia, PA and Hutzel Hospital, Detroit, MI. The study was approved by the respective Institutional Review Boards and informed consent was obtained from mothers prior to collection of the samples. Controls were derived from singleton pregnancies delivered at term of mothers with no prior history of PPROM or preterm birth. Cases were singleton pregnancies complicated by PPROM, defined as fetal membrane rupture prior to 37 weeks of completed gestation. PPROM was diagnosed by vaginal pooling of fluid and positive nitrazine and fern tests. Pregnancies with fetal malformations or medical complications requiring induction of labor were excluded from both the control and case groups.
Isolation and culture of amnion mesenchymal cells
Cultures of amnion mesenchymal cells were prepared from fetal membranes obtained from patients with term gestations. After separation of the amnion from the chorion, pieces of amnion were minced and then digested with 1 mg/ml of collagenase A 7 (0.5 ng/ml), human fibroblast growth factor (1.0 ng/ml), insulin (5 µg/ml), gentamicin (50 µg/ml), and amphotericin B (50 µg/ml). All cells were maintained at 37˚C under an atmosphere of 5% CO 2 in air. Luciferase and β-galactosidase assays After 24 h of culture, transfected cells were collected into lysis buffer, and luciferase and β-galactosidase assays were performed using reagent systems purchased from Promega (Madison, WI, USA). Relative luciferase units (RLU) were calculated as the ratio of luciferase light units /β-galactosidase activity. DNA from cultured cells and from umbilical cords was isolated by method using a digestion with proteinase K and extraction with phenol/chloroform/isoamyl alcohol (23).
DNA from cheek swabs was isolated in 50 mM NaOH and 1M Tris (pH 8.0). DNA from blood samples was extracted using QIAamp ® DNA Mini Kits (QIAGEN, Valencia, CA, USA) as described by the manufacturer. The extracted genomic DNA was stored at -70°C for subsequent use.
MMP-1 promoter genotyping
We employed two different methods to genotype the nt -1607 MMP-1 promoter ; followed by 7 min extension at 72 °C). PCR products were electrophoresed in the presence of an internal size standard (Genescan 500) on 4% acrylamide, 5 M urea denaturing gels using a 377 DNA sequencer (PE Applied Biosystems). Gels were run for 2.5 h at 3000 V. Genotypes were determined using the Genescan Analysis and Genotyper 
programs (PE Applied Biosystems). Method 2 (restriction endonuclease
Results
Characterization of cultured amnion mesenchymal cells
Virtually all of the isolated amnion mesenchymal cells stained positive for vimentin after one passage, whereas only few cells stained for cytokeratin ( Figure   1A ,B,C). Greater than 95% of cells were vimentin positive and cytokeratin negative in the analysis of different isolates. These observations indicate that the preparations used in our experiments were highly enriched for cells from the mesenchymal lineage.
Relative activities of MMP-1 promoters with the -1607 2G or 1G alleles
We examined the activities of the two promoter alleles transfected into various cell hosts. The relative promoter activities of the 2G allele to the 1G allele are shown in Table 1 . Consistent with the report of Rutter et al. (19) , we found that in all cell contexts tested, the 2G allele displayed stronger activity than the 1G allele. The difference was greatest in A2058 melanoma cells, and was more than 2-fold higher in amnion-derived cells including WISH cells and amnion mesenchymal cells. When tansfected amnion mesenchymal cells were treated with PMA (50 ng/ml), we consistently found a modest increase in 2G promoter activity (20-30%) above the DMSO control, but no response of the 1G promoter. The modest impact of PMA appears to be due to the fact that the transfection reagents activate signaling pathways mediating MMP-1 gene transcription.
Thus, the act of plasmid introduction was equivalent to a PMA stimulus.
PMA treatment increases levels of a nuclear protein binding with high affinity to the 2G There were no statistically significant differences in maternal age, gravidity, and parity between the PPROM and the control group (Table 3) . As expected, there were statistically significant differences in gestational age at birth and birth weight in these two groups. In the PPROM group, the gestational age at delivery was 7 weeks shorter and birth weight was 1378 g lower than in the control group.
We found a significant difference in allele and genotype frequencies of the fetus for the -1607 MMP-1 promoter polymorphism between patients with PPROM and those in the control group ( 
Discussion
Our observations document that the insertion of a guanine nucleotide (G) at -1607 in the MMP-1 promoter, previously shown to create an Ets binding site and increased promoter activity in transfected cells (19) and to be associated with increased levels of MMP-1 mRNA in ovarian cancer cells (27) The increased transcription of the endogenous 2G allele is presumably driven by the binding of a transcription factor whose level or activity is increased by PMA. The PMA-induced factor is likely to be a member of the Ets family of transcription factors (28) . However, since Rutter et al. (19) found that binding of recombinant Ets-1 to an oligonucleotide containing 2G at -1607 was increased in the presence of c-Jun, it is possible that the augmented binding of nuclear proteins to the 2G allele were observed is the result of PMA induction of c-Jun or another Jun protein.
The impact of the -1607 MMP-1 polymorphism on cellular functions in vivo has been explored in case-control studies in women with gynecologic cancers which revealed that ovarian and endometrial cancers (27, 29) 
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